IBDEI0ZW ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16546,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,16547,0)
 ;;=E11.319^^88^850^19
 ;;^UTILITY(U,$J,358.3,16547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16547,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Reinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,16547,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,16547,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,16548,0)
 ;;=Z72.4^^88^850^30
 ;;^UTILITY(U,$J,358.3,16548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16548,1,3,0)
 ;;=3^Diet & Eating Habits,Inappropriate
 ;;^UTILITY(U,$J,358.3,16548,1,4,0)
 ;;=4^Z72.4
 ;;^UTILITY(U,$J,358.3,16548,2)
 ;;=^5063257
 ;;^UTILITY(U,$J,358.3,16549,0)
 ;;=R68.81^^88^850^31
 ;;^UTILITY(U,$J,358.3,16549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16549,1,3,0)
 ;;=3^Early Satiety
 ;;^UTILITY(U,$J,358.3,16549,1,4,0)
 ;;=4^R68.81
 ;;^UTILITY(U,$J,358.3,16549,2)
 ;;=^5019554
 ;;^UTILITY(U,$J,358.3,16550,0)
 ;;=E34.9^^88^850^32
 ;;^UTILITY(U,$J,358.3,16550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16550,1,3,0)
 ;;=3^Endocrine Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16550,1,4,0)
 ;;=4^E34.9
 ;;^UTILITY(U,$J,358.3,16550,2)
 ;;=^5002777
 ;;^UTILITY(U,$J,358.3,16551,0)
 ;;=R62.7^^88^850^33
 ;;^UTILITY(U,$J,358.3,16551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16551,1,3,0)
 ;;=3^Failure to Thrive,Adult
 ;;^UTILITY(U,$J,358.3,16551,1,4,0)
 ;;=4^R62.7
 ;;^UTILITY(U,$J,358.3,16551,2)
 ;;=^322019
 ;;^UTILITY(U,$J,358.3,16552,0)
 ;;=R63.3^^88^850^34
 ;;^UTILITY(U,$J,358.3,16552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16552,1,3,0)
 ;;=3^Feeding Difficulty
 ;;^UTILITY(U,$J,358.3,16552,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,16552,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,16553,0)
 ;;=E87.8^^88^850^35
 ;;^UTILITY(U,$J,358.3,16553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16553,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,16553,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,16553,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,16554,0)
 ;;=E87.70^^88^850^36
 ;;^UTILITY(U,$J,358.3,16554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16554,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,16554,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,16554,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,16555,0)
 ;;=R73.01^^88^850^50
 ;;^UTILITY(U,$J,358.3,16555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16555,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,16555,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,16555,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,16556,0)
 ;;=R73.02^^88^850^51
 ;;^UTILITY(U,$J,358.3,16556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16556,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,16556,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,16556,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,16557,0)
 ;;=E83.119^^88^850^37
 ;;^UTILITY(U,$J,358.3,16557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16557,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,16557,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,16557,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,16558,0)
 ;;=E83.52^^88^850^38
 ;;^UTILITY(U,$J,358.3,16558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16558,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,16558,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,16558,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,16559,0)
 ;;=E11.65^^88^850^22
 ;;^UTILITY(U,$J,358.3,16559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16559,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,16559,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,16559,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,16560,0)
 ;;=R73.9^^88^850^39
